O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+7.57%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$4.43B
AUM Growth
–
Cap. Flow
+$4.4B
Cap. Flow
% of AUM
99.27%
Top 10 Holdings %
Top 10 Hldgs %
40.13%
Holding
117
New
107
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Amgen
AMGN
|
$258M |
| 2 |
Gilead Sciences
GILD
|
$247M |
| 3 |
Biogen
BIIB
|
$221M |
| 4 |
Merck
MRK
|
$192M |
| 5 |
Viatris
VTRS
|
$155M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 85.21% |
| 2 | Financials | 2.18% |
| 3 | Technology | 0.15% |
| 4 | Utilities | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Abbott
ABT
$230B
| $16.7M | 0.35% |
+480,000
| New | +$16.7M |
|
52
Supernus Pharmaceuticals
SUPN
$2.52B
| $16.1M | 0.34% |
+2,496,200
| New | +$16.1M |
|
|
SQNM
53
DELISTED
SEQUENOM INC NEW
SQNM
| $15.2M | 0.32% |
+3,603,000
| New | +$15.2M |
|
54
Pacira BioSciences
PCRX
$1.22B
| $14.4M | 0.31% |
+498,000
| New | +$14.4M |
|
|
ASTX
55
DELISTED
ASTEX PHARMACEUTICALS, INC COM
ASTX
| $13.4M | 0.28% |
+3,256,100
| New | +$13.4M |
|
56
Puma Biotechnology
PBYI
$258M
| $13.1M | 0.28% |
+295,000
| New | +$13.1M |
|
|
WCG
57
DELISTED
Wellcare Health Plans, Inc.
WCG
| $12.9M | 0.27% |
+233,000
| New | +$12.9M |
|
|
DRTX
58
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
| $12.9M | 0.27% |
+1,785,714
| New | +$12.9M |
|
|
RCPT
59
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $12.8M | 0.27% |
+644,450
| New | +$12.8M |
|
|
HITK
60
DELISTED
HI-TECH PHARMACAL INC
HITK
| $12.3M | 0.26% |
+371,200
| New | +$12.3M |
|
61
Bausch Health
BHC
$2.72B
| $11.9M | 0.25% |
+138,000
| New | +$11.9M |
|
|
PTLA
62
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $11.8M | 0.25% |
+480,319
| New | +$11.8M |
|
63
Community Health Systems
CYH
$392M
| $11.3M | 0.24% |
+292,820
| New | +$11.3M |
|
64
Baxter International
BAX
$12.1B
| $11.3M | 0.24% |
+299,715
| New | +$11.3M |
|
|
ALBO
65
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $11.2M | 0.24% |
+89,678
| New | +$11.2M |
|
|
AMBI
66
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $10.4M | 0.22% |
+1,490,769
| New | +$10.4M |
|
67
Neurocrine Biosciences
NBIX
$13.5B
| $10.3M | 0.22% |
+768,000
| New | +$10.3M |
|
68
Medtronic
MDT
$118B
| $9.9M | 0.21% |
+192,300
| New | +$9.9M |
|
69
Dynavax Technologies
DVAX
$1.19B
| $9.89M | 0.21% |
+898,600
| New | +$9.89M |
|
70
Xoma
XOMA
$421M
| $9.39M | 0.2% |
+129,296
| New | +$9.39M |
|
71
Cardinal Health
CAH
$36B
| $8.94M | 0.19% |
+189,300
| New | +$8.94M |
|
72
McKesson
MCK
$85.9B
| $8.7M | 0.18% |
+76,000
| New | +$8.7M |
|
|
ECYT
73
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $8.69M | 0.18% |
+662,000
| New | +$8.69M |
|
|
PTX
74
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $8.38M | 0.18% |
+232,080
| New | +$8.38M |
|
75
DaVita
DVA
$9.72B
| $7.85M | 0.17% |
+130,000
| New | +$7.85M |
|